These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3925873)
61. [Resistance of Enterobacteriaceae to antibiotics. II. R factor in Escherichia coli (study in 210 patients)]. Turcu T Bacteriol Virusol Parazitol Epidemiol (Bucur); 1974 May; 19(3):241-5. PubMed ID: 4601942 [No Abstract] [Full Text] [Related]
62. Cephalexin in the management of bacteriuria. Fennell RS; Walker RD; Garin EH; Richard GA Clin Pediatr (Phila); 1975 Oct; 14(10):934-8. PubMed ID: 1100295 [TBL] [Abstract][Full Text] [Related]
63. Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers. Kadri SS Crit Care Med; 2020 Jul; 48(7):939-945. PubMed ID: 32282351 [No Abstract] [Full Text] [Related]
64. Antibiotics of choice in suspected serious sepsis. Levin S J Antimicrob Chemother; 1981 Jul; 8 Suppl A():133-42. PubMed ID: 7263560 [No Abstract] [Full Text] [Related]
65. Antibiotic production by new form-genera of the Actinomycetales. I. Sporangiomycin, an antibacterial agent isolated from Planomonospora parontospora var. antibiotica var. nov. Thiemann JE; Coronelli C; Pagani H; Beretta G; Tamoni G J Antibiot (Tokyo); 1968 Sep; 21(9):525-31. PubMed ID: 4388267 [No Abstract] [Full Text] [Related]
66. Which antibiotic for bacteria with inducible class I beta-lactamase? Weinbren MJ; Perinpanayagam RM Lancet; 1986 Jan; 1(8472):102. PubMed ID: 2867302 [No Abstract] [Full Text] [Related]
67. Basis and results of therapy with Beta-lactam antibiotics in experimental infections. Rolinson GN Infection; 1980; Suppl 1():30-4. PubMed ID: 7399710 [TBL] [Abstract][Full Text] [Related]
68. Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge. Wollein Waldetoft K; Brown SP PLoS Biol; 2017 Dec; 15(12):e2003533. PubMed ID: 29283999 [TBL] [Abstract][Full Text] [Related]
69. Comparative study of three routes of administration of sisomicin. Meunier-Carpentier F; Staquet M; Klastersky J J Clin Pharmacol; 1976; 16(11-12):625-30. PubMed ID: 993357 [TBL] [Abstract][Full Text] [Related]
70. [Fatal colitis due to Pseudomonas aeruginosa (Bacillus pyocyaneus) following antibiotic treatment in a patient with sepsis caused by Streptococcus viridans]. DENIE JJ Ned Tijdschr Geneeskd; 1959 Nov; 103():2263-6. PubMed ID: 13815915 [No Abstract] [Full Text] [Related]
71. The endless increase of antibiotic resistance in Enterobacteriaceae and the activity of new compounds to face the challenge. Morosini MI Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):477-479. PubMed ID: 28964321 [No Abstract] [Full Text] [Related]
74. [Studies on the problem of chemical resistance]. JENSEN KA; KIAER I Ugeskr Laeger; 1963 Feb; 125():275-82. PubMed ID: 13957632 [No Abstract] [Full Text] [Related]
75. LYMPHOTROPIC ADMINISTRATION OF ANTIBACTERIAL DRUGS - A METHOD OF RATIONAL ANTIBIOTIC THERAPY. Duzhyi ID; Shymko VV; Oleshchenko HP; Piatykop HI Wiad Lek; 2022; 75(7):1688-1692. PubMed ID: 35962682 [TBL] [Abstract][Full Text] [Related]
76. Antibiotic susceptibility testing by a standardized single disk method. Bauer AW; Kirby WM; Sherris JC; Turck M Am J Clin Pathol; 1966 Apr; 45(4):493-6. PubMed ID: 5325707 [No Abstract] [Full Text] [Related]
77. Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques. O'Neill AJ; Chopra I Expert Opin Investig Drugs; 2004 Aug; 13(8):1045-63. PubMed ID: 15268641 [TBL] [Abstract][Full Text] [Related]
78. [On persistence of antibiotic-sensitive microorganisms in antibiotic therapy]. von WASIELEWSKI ; ALBRECHT J; von GRAEVENITZ Arzneimittelforschung; 1960 Mar; 10():186-8. PubMed ID: 13843006 [No Abstract] [Full Text] [Related]
79. Antibacterials: Resistance-guided discovery of new antibiotics. Flemming A Nat Rev Drug Discov; 2013 Nov; 12(11):826. PubMed ID: 24136397 [No Abstract] [Full Text] [Related]
80. [Use of antibioticograms for individual programs of antibacterial therapy]. Navashin SM; Chaĭkovskaia SM; Rezvan SP; Treskina OS Antibiot Med Biotekhnol; 1985 Mar; 30(3):212-21. PubMed ID: 3925873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]